Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haichen Yang

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Epilepsia|June 23, 2015
Perampanel efficacy and safety by gender: Subanalysis of phase III randomized clinical studies in subjects with partial seizuresBlanca Vazquez, Haichen Yang, Betsy Williams, et al.
Epilepsy & Behavior : E&B|June 16, 2010
Assessment of behavioral and emotional functioning using standardized instruments in children and adolescents with partial-onset seizures treated with adjunctive levetiracetam in a randomized, placebo-controlled trialChristine de la Loge, Scott J Hunter, Jimmy Schiemann, et al.
Scientific Reports|January 13, 2026
Hierarchical contextual information aggregation for polyp segmentationLin Li, Haichen Yang, Jialing Zhang, et al.
Epilepsy Research|June 20, 2015
Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trialsHaichen Yang, Antonio Laurenza, Betsy Williams, et al.
Epilepsy Research|June 20, 2015
Efficacy and safety of perampanel in patients with drug-resistant partial seizures after conversion from double-blind placebo to open-label perampanelGeorgia Montouris, Haichen Yang, Betsy Williams, et al.
Epilepsia|August 26, 2009
Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trialPaul M Levisohn, Mark Mintz, Scott J Hunter, et al.
Epilepsy Research|December 15, 2015
Efficacy and tolerability of adjunct perampanel based on number of antiepileptic drugs at baseline and baseline predictors of efficacy: A phase III post-hoc analysisTracy Glauser, Antonio Laurenza, Haichen Yang, et al.
Epilepsy & Behavior : E&B|August 23, 2017
Perampanel with concomitant levetiracetam and topiramate: Post hoc analysis of adverse events related to hostility and aggressionSteve Chung, Betsy Williams, Cindy Dobrinsky, et al.
Biologics : Targets & Therapy|March 3, 2025
Berberine Intervention Mitigates Myocardial Ischemia-Reperfusion Injury in a Rat Model: Mechanistic Insights via miR-184 SignalingHaichen Yang, Gang Cao, Xia Li, et al.
Chemosphere|March 17, 2024
The unique biodegradation pathway of benzo[a]pyrene in moderately halophilic Pontibacillus chungwhensis HN14Zhihui Qian, Haichen Yang, Jin Li, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Epilepsia|June 23, 2015
Perampanel efficacy and safety by gender: Subanalysis of phase III randomized clinical studies in subjects with partial seizuresBlanca Vazquez, Haichen Yang, Betsy Williams, et al.
Epilepsy & Behavior : E&B|June 16, 2010
Assessment of behavioral and emotional functioning using standardized instruments in children and adolescents with partial-onset seizures treated with adjunctive levetiracetam in a randomized, placebo-controlled trialChristine de la Loge, Scott J Hunter, Jimmy Schiemann, et al.
Scientific Reports|January 13, 2026
Hierarchical contextual information aggregation for polyp segmentationLin Li, Haichen Yang, Jialing Zhang, et al.
Epilepsy Research|June 20, 2015
Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trialsHaichen Yang, Antonio Laurenza, Betsy Williams, et al.
Epilepsy Research|June 20, 2015
Efficacy and safety of perampanel in patients with drug-resistant partial seizures after conversion from double-blind placebo to open-label perampanelGeorgia Montouris, Haichen Yang, Betsy Williams, et al.
Epilepsia|August 26, 2009
Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trialPaul M Levisohn, Mark Mintz, Scott J Hunter, et al.
Epilepsy Research|December 15, 2015
Efficacy and tolerability of adjunct perampanel based on number of antiepileptic drugs at baseline and baseline predictors of efficacy: A phase III post-hoc analysisTracy Glauser, Antonio Laurenza, Haichen Yang, et al.
Epilepsy & Behavior : E&B|August 23, 2017
Perampanel with concomitant levetiracetam and topiramate: Post hoc analysis of adverse events related to hostility and aggressionSteve Chung, Betsy Williams, Cindy Dobrinsky, et al.
Biologics : Targets & Therapy|March 3, 2025
Berberine Intervention Mitigates Myocardial Ischemia-Reperfusion Injury in a Rat Model: Mechanistic Insights via miR-184 SignalingHaichen Yang, Gang Cao, Xia Li, et al.
Chemosphere|March 17, 2024
The unique biodegradation pathway of benzo[a]pyrene in moderately halophilic Pontibacillus chungwhensis HN14Zhihui Qian, Haichen Yang, Jin Li, et al.
Pageof 8